Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Biotie Therapies Corp.

http://www.biotie.com/

Latest From Biotie Therapies Corp.

ATAI Raises $125m Series C To Expand The Boundaries In Mental Health

The funding will be used to support clinical and preclinical development at its portfolio companies, with 8-10 programs in the clinic in 2021.

BioPharmaceutical Clinical Trials

Acutus Medical Inks Marketing Deal With Biotronik, Mapping Its Way To Electrophysiologists Outside US

Biotronik will help Acutus to bring its cardiac mapping software and guidance system to electrophysiologists worldwide.

Cardiovascular Cardiology

Sandoz Will Wait A Decade On Amantadine

Sandoz will be able to launch a generic of Adamas’ amantadine-based Gocovri brand in the US from March 2030. But a patent-litigation settlement permits an earlier entry if sales of the dyskinesia brand decline.

Intellectual Property Neurology

Astellas Strengthens Next-Gen I-O Hand With $665m Xyphos Buy

Astellas pays to play in next-generation immuno-oncology through deal for young, privately held US venture and its novel modulation platform.

M & A ImmunoOncology
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
  • Other Names / Subsidiaries
    • Elbion GmbH
    • Synosia Therapeutics, Inc.
UsernamePublicRestriction

Register